Daan Pieren

144 Chapter 5 ACKNOWLEDGEMENTS We thank all participants of the ILI-3, NVI-255, and FFX cohort studies, as well as the blood donors at Sanquin Blood Supply Foundation. We also thank Elske Bijvank, Joyce Greeber, Nynke Rots, Ronald Jacobi, Roos van Schuijlenburg, and Marion Hendriks for sample processing and assisting with sample selection. We thank Sara van den Berg and Marjan Bogaard-van Maurik for performing and interpreting CMV serology assays, and Paul Wackers for providing the in- house RNA-seq analysis pipeline. We thank Patricia Kaaijk for critically reviewing the manuscript. Lastly, we thank Maarten Emmelot, Willem van Eden (Utrecht University), the division of Infectious Diseases and Immunology (Utrecht University) and the Center for Immunology of Infectious Diseases and Vaccines (RIVM) for useful discussions. This study was supported by the Dutch Ministry of Health, Welfare and Sport.